Cronos Group Inc. Common Share (CRON) Stock Price

CRONStock

$3.21+31.41%52W

Market Cap$1.18B

P/E24.31x

PEG Ratio—

Div yield—

Beta1.28

CRON Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)17.83%

Price vs S&P 500 (4W)-1.03%

VGM Score64.41

P/E Ratio (Annual)24.31x

P/CF (Annual)45.73x

Book Value / Share (Quarterly)$2.88

P/TBV (Annual)0.90x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)16.84%

Cash Flow / Share (Quarterly)$0.13

Price vs S&P 500 (YTD)14.74%

Gross Margin (TTM)46.48%

Net Profit Margin (TTM)39.08%

EPS (TTM)$0.18

10-Day Avg Trading Volume0.07M

EPS Excl Extra (TTM)$0.18

Revenue Growth (5Y)25.70%

EPS (Annual)$-0.02

ROI (Annual)-0.86%

Gross Margin (Annual)43.26%

Net Profit Margin (5Y Avg)-154.41%

Cash / Share (Quarterly)$2.15

P/E Basic Excl Extra (TTM)16.90x

Revenue Growth QoQ (YoY)58.44%

EPS Growth (5Y)-49.98%

P/E Normalized (Annual)24.31x

ROA (Last FY)-0.79%

Revenue Growth TTM (YoY)37.46%

EBITD / Share (TTM)$-0.00

ROE (5Y Avg)-9.62%

Operating Margin (TTM)-1.36%

Cash Flow / Share (Annual)$-0.00

P/B Ratio1.11x

P/B Ratio (Quarterly)0.97x

Net Income / Employee (Annual)$-15,100

EV / Revenue (TTM)4.00x

Net Interest Coverage (TTM)-44.46x

ROA (TTM)5.92%

EPS Growth QoQ (YoY)127.85%

EV / EBITDA (TTM)2309.50x

EPS Incl Extra (Annual)$-0.02

Current Ratio (Annual)19.59x

Quick Ratio (Quarterly)15.15x

3-Month Avg Trading Volume0.14M

52-Week Price Return31.41%

EV / Free Cash Flow (Annual)37.72x

P/E Incl Extra (TTM)16.90x

Revenue / Employee (TTM)$286,100

Tangible BV / Share (Quarterly)$2.86

P/S Ratio (Annual)8.07x

Asset Turnover (Annual)0.12x

52-Week High$4.99

Operating Margin (5Y Avg)-232.78%

EPS Excl Extra (Annual)$-0.02

CapEx CAGR (5Y)-5.94%

Tangible BV CAGR (5Y)-7.95%

26-Week Price Return27.73%

Quick Ratio (Annual)18.45x

13-Week Price Return17.53%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)16.18x

Enterprise Value$715.95M

Revenue / Share Growth (5Y)23.53%

Asset Turnover (TTM)0.15x

Book Value / Share Growth (5Y)-9.61%

Revenue / Employee (Annual)$234,200

Inventory Turnover (Annual)2.08x

Pretax Margin (Annual)-11.68%

Cash / Share (Annual)$2.18

3-Month Return Std Dev41.31%

Gross Margin (5Y Avg)14.31%

Net Income / Employee (TTM)$111,800

ROE (Last FY)-0.86%

Net Interest Coverage (Annual)-0.43x

EPS Basic Excl Extra (Annual)$-0.02

P/FCF (TTM)23.93x

Receivables Turnover (TTM)5.66x

EV / Free Cash Flow (TTM)14.48x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.18

Receivables Turnover (Annual)5.92x

ROI (TTM)6.48%

P/S Ratio (TTM)6.61x

Pretax Margin (5Y Avg)-146.04%

Revenue / Share (Annual)$0.38

Tangible BV / Share (Annual)$2.84

Forward P/E27.44x

Price vs S&P 500 (52W)15.88%

P/E Ratio (TTM)16.90x

EPS Growth TTM (YoY)313.00%

Year-to-Date Return26.67%

5-Day Price Return-1.30%

EPS Normalized (Annual)$-0.02

ROA (5Y Avg)-9.20%

Net Profit Margin (Annual)-6.44%

Month-to-Date Return-2.98%

Cash Flow / Share (TTM)$-0.34

EBITD / Share (Annual)$-0.04

Operating Margin (Annual)-11.87%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)19.70x

ROI (5Y Avg)-9.62%

P/E Excl Extra (TTM)16.90x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.18

P/TBV (Quarterly)0.98x

P/B Ratio (Annual)0.89x

Inventory Turnover (TTM)2.02x

Pretax Margin (TTM)38.23%

Book Value / Share (Annual)$2.87

Price vs S&P 500 (13W)14.84%

Net Margin Growth (5Y)-62.81%

Beta1.28x

P/FCF (Annual)207.94x

Revenue / Share (TTM)$0.48

ROE (TTM)6.48%

52-Week Low$3.23

vGradeC

gGradeB

mGradeA

vgmGradeB

CRON Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.01	$0.13	+802.14%(+$0.11)
Q1 2026	May 11, 2026	$0.01	$0.05	+682.29%(+$0.05)
Q4 2025	Feb 26, 2026	$0.02	$0.00	-100.00%(-$0.02)
Q3 2025	Nov 6, 2025	$0.00	$0.10	+0.00%(+$0.10)
Q2 2025	Aug 7, 2025	-$0.03	-$0.14	-391.36%(-$0.11)

CRON Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About Cronos Group Inc. Common Share

Cronos Group Inc is a cannabis company with operations in Canada, Israel, and other markets, generating the majority of its revenue from Canada. The company's brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. Cronos focuses on cannabis research, technology, and product development to drive competitive differentiation.